Nutex Health Inc. (NUTX): Price and Financial Metrics
GET POWR RATINGS... FREE!
NUTX POWR Grades
- Growth is the dimension where NUTX ranks best; there it ranks ahead of 97.29% of US stocks.
- NUTX's strongest trending metric is Stability; it's been moving down over the last 179 days.
- NUTX's current lowest rank is in the Value metric (where it is better than 13.71% of US stocks).
NUTX Stock Summary
- With a year-over-year growth in debt of 5,371.07%, NUTEX HEALTH INC's debt growth rate surpasses 99.43% of about US stocks.
- In terms of twelve month growth in earnings before interest and taxes, NUTEX HEALTH INC is reporting a growth rate of 4,979.36%; that's higher than 99.56% of US stocks.
- As for revenue growth, note that NUTX's revenue has grown 1,066.85% over the past 12 months; that beats the revenue growth of 99.12% of US companies in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to NUTEX HEALTH INC are TDOC, MARA, PSFE, MLP, and SWN.
- NUTX's SEC filings can be seen here. And to visit NUTEX HEALTH INC's official web site, go to www.igambit.com.
NUTX Valuation Summary
- NUTX's price/earnings ratio is -1.6; this is 106.75% lower than that of the median Technology stock.
- NUTX's price/sales ratio has moved down 314.3 over the prior 60 months.
Below are key valuation metrics over time for NUTX.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| NUTX | 2023-03-21 | 3.1 | 7.0 | -1.6 | -2.3 |
| NUTX | 2023-03-20 | 3.1 | 7.1 | -1.6 | -2.3 |
| NUTX | 2023-03-17 | 3.2 | 7.2 | -1.6 | -2.3 |
| NUTX | 2023-03-16 | 3.2 | 7.3 | -1.6 | -2.3 |
| NUTX | 2023-03-15 | 3.2 | 7.3 | -1.6 | -2.3 |
| NUTX | 2023-03-14 | 3.4 | 7.7 | -1.7 | -2.4 |
NUTX Stock Price Chart Interactive Chart >
NUTX Price/Volume Stats
| Current price | $1.05 | 52-week high | $52.80 |
| Prev. close | $0.99 | 52-week low | $0.50 |
| Day low | $0.95 | Volume | 907,500 |
| Day high | $1.07 | Avg. volume | 1,322,681 |
| 50-day MA | $1.32 | Dividend yield | N/A |
| 200-day MA | $2.10 | Market Cap | 683.47M |
Nutex Health Inc. (NUTX) Company Bio
Nutex Health, Inc. operates as technology-enabled healthcare services. It has two divisions: a Hospital Division and a Population Health Management Division. The company was founded in 2011 and is headquartered in Houston, TX.
Latest NUTX News From Around the Web
Below are the latest news stories about NUTEX HEALTH INC that investors may wish to consider to help them evaluate NUTX as an investment opportunity.
NUTEX HEALTH PROVIDES UPDATE ON ITS MEDICAL GROUP IN HOUSTONNutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 19 state-of-the-art micro hospitals in 8 states and primary care-centric, risk-bearing physician networks, today provides an update on Houston Physicians IPA, its independent practice association ("IPA") in Houston. |
NUTEX HEALTH INC. REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTSNutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 19 state-of-the-art micro hospitals in 8 states and primary care-centric, risk-bearing physician networks, today announced fourth quarter and fiscal year 2022 financial results for the twelve months ended December 31, 2022. |
NUTEX HEALTH OPENS FORT SMITH ER & HOSPITAL IN ARKANSASNutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, healthcare management and operations company comprised of 21 micro-hospitals in 8 states and primary care-centric, risk-bearing physician networks, is pleased to announce the opening of its 22nd healthcare facility, Fort Smith ER & Hospital, in Fort Smith, Arkansas. |
NUTEX HEALTH CEO TO BE A PANEL SPEAKER AT THE 2023 McDERMOTT AND EY HEALTHCARE MEETING IN SAN FRANCISCONutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 8 states and primary care-centric, risk-bearing physician networks, today announced that Tom Vo, M.D., MBA (CEO and Chairman) will be a panel speaker at the McDermott and EY Meeting on January 10, 2023 at the 2023 J.P. Morgan Healthcare Conference in San Francisco, California. The Panel is titled: Hospita |
NUTEX HEALTH TO PRESENT AT THE 41ST ANNUAL J.P. MORGAN HEALTHCARE CONFERENCENutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 8 states and primary care-centric, risk-bearing physician networks, today announced that Tom Vo, M.D., MBA (CEO and Chairman), Warren Hosseinion, M.D. (President) and Jon Bates (CFO) are scheduled to present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, California on Thursday, Jan |
NUTX Price Returns
| 1-mo | -16.67% |
| 3-mo | N/A |
| 6-mo | -36.75% |
| 1-year | -73.42% |
| 3-year | N/A |
| 5-year | -96.52% |
| YTD | -44.74% |
| 2022 | -53.88% |
| 2021 | N/A |
| 2020 | 0.00% |
| 2019 | -20.00% |
| 2018 | -90.00% |
Loading social stream, please wait...